Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer

Volume: 120, Issue: 5, Pages: 522 - 526
Published: Feb 12, 2019
Abstract
HER2 is the only validated predictive biomarker in gastro-oesophageal carcinoma (GOC). However, several factors, such as heterogeneity in protein expression, shortage of evaluable tumour tissue and need for quick target assessment, underline the usefulness of a pre-screening tool in order to anticipate HER2 status. Data from 723 consecutive GOC analysed for HER2 at four Italian Institutions were collected. HER2 positivity was defined as 3+ by...
Paper Details
Title
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
Published Date
Feb 12, 2019
Volume
120
Issue
5
Pages
522 - 526
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.